Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To explore in a multicenter international prospective randomized study (phase III) whether rituximab combined with the standard French LMB chemotherapy scheme results in a higher rate of EFS than the LMB chemotherapy scheme alone in patients older than 18 years with Burkitt lymphoma or ALL 3.
Critère d'inclusion
- Burkitt lymphoma